The Trust is supporting a seven year partnership between the Universities of Oxford and Birmingham to speed up the development of novel treatments for arthritis. The partnership, based at the Institute of Translational Medicine in Birmingham and the Kennedy Institute of Rheumatology at Oxford will harness the existing research strengths of both universities in order to accelerate the development and testing of new therapies for patients. Under the leadership of Professor Chris Buckley and Professor Fiona Powrie, the Arthritis Therapy Acceleration Programme (A-TAP) will develop and test therapies based on the underlying causes of inflammatory disease, rather than simply treating the clinical symptoms.
